Jacobs & CO Novartis Ag Transaction History
Jacobs & CO
- $983 Million
- Q4 2024
A detailed history of Jacobs & CO transactions in Novartis Ag stock. As of the latest transaction made, Jacobs & CO holds 2,750 shares of NVS stock, worth $268,207. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,750
Previous 2,750
-0.0%
Holding current value
$268,207
Previous $316,000
15.51%
% of portfolio
0.03%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding NVS
# of Institutions
1,433Shares Held
131MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.19 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.17 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$789 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$681 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$563 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $210B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...